Publications

Found 85 results
Filters: %CE%B2-adrenergic-receptor-mediated-negative-regulation-group-2-innate-lymphoid-cell is   [Clear All Filters]
Journal Article
Moriyama S, Brestoff JR, Flamar A-L, Moeller JB, Klose CSN, Rankin LC, Yudanin NA, Monticelli LA, Putzel GGarbès, Rodewald H-R et al..  2018.  β-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses.. Science. 359(6379):1056-1061.
Zhou W, Zhou L, Zhou J, Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF.  2022.  ZBTB46 defines and regulates ILC3s that protect the intestine.. Nature. 609(7925):159-165.
Nice TJ, Osborne LC, Tomov VT, Artis D, E Wherry J, Virgin HW.  2016.  Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.. PLoS Pathog. 12(6):e1005684.
Howitt MR, Lavoie S, Michaud M, Blum AM, Tran SV, Weinstock JV, Gallini CAnn, Redding K, Margolskee RF, Osborne LC et al..  2016.  Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut.. Science. 351(6279):1329-33.
Feng X, Andersson T, Gschwend J, Flüchter P, Berest I, Muff JL, Carchidi D, Lechner A, de Tenorio JC, Brander N et al..  2024.  Tuft cell IL-17RB restrains IL-25 bioavailability and reveals context-dependent ILC2 hypoproliferation.. bioRxiv.
Li Z, Ma R, Tang H, Guo J, Shah Z, Zhang J, Liu N, Cao S, Marcucci G, Artis D et al..  2024.  Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death.. Cell. 187(3):624-641.e23.
Kabata H, Flamar A-L, Mahlakõiv T, Moriyama S, Rodewald H-R, Ziegler SF, Artis D.  2020.  Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation.. Mucosal Immunol.
Mahlakõiv T, Flamar A-L, Johnston LK, Moriyama S, Putzel GG, Bryce PJ, Artis D.  2019.  Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33.. Sci Immunol. 4(35)
Zhang W, Artis D.  2024.  Stressing out the intestinal microbiota via a brain-neuroglandular circuit.. Cell Res.
Gerhardt RE, Peskoe ST, Rao RN, Hudson JB.  1982.  Spontaneous remission in idiopathic membranous glomerulonephritis with crescents.. South Med J. 75(3):356-9.
Mayassi T, Li C, Segerstolpe Å, Brown EM, Weisberg R, Nakata T, Yano H, Herbst P, Artis D, Graham DB et al..  2024.  Spatially restricted immune and microbiota-driven adaptation of the gut.. Nature. 636(8042):447-456.
Yudanin NA, Schmitz F, Flamar A-L, Thome JJC, Wojno ETait, Moeller JB, Schirmer M, Latorre IJ, Xavier RJ, Farber DL et al..  2019.  Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity.. Immunity. 50(2):505-519.e4.
Leichner TM, Satake A, Harrison VSanoe, Tanaka Y, Archambault AS, Kim BS, Siracusa MC, Leonard WJ, Naji A, Wu GF et al..  2017.  Skin-derived TSLP systemically expands regulatory T cells.. J Autoimmun. 79:39-52.
Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V et al..  2017.  Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.. Inflamm Bowel Dis. 23(6):903-911.
Sawant DV, Gravano DM, Vogel P, Giacomin P, Artis D, Vignali DAA.  2014.  Regulatory T cells limit induction of protective immunity and promote immune pathology following intestinal helminth infection.. J Immunol. 192(6):2904-12.
J Blander M, Longman RS, Iliev ID, Sonnenberg GF, Artis D.  2017.  Regulation of inflammation by microbiota interactions with the host.. Nat Immunol. 18(8):851-860.
Mayassi T, Li C, Segerstolpe Å, Brown EM, Weisberg R, Nakata T, Yano H, Herbst P, Artis D, Graham DB et al..  2025.  Publisher Correction: Spatially restricted immune and microbiota-driven adaptation of the gut.. Nature. 637(8044):E10.
Arifuzzaman M, Collins N, Guo C-J, Artis D.  2024.  Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation.. Immunity. 57(1):14-27.
Sonnenberg GF, Artis D.  2019.  Novel connections and precision approaches.. Nat Rev Immunol. 19(2):75-76.
Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.
Tsou AM, Yano H, Parkhurst CN, Mahlakõiv T, Chu C, Zhang W, He Z, Jarick KJ, Zhong C, Putzel GG et al..  2022.  Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.. Nature. 611(7937):787-793.
Wallrapp A, Riesenfeld SJ, Burkett PR, Abdulnour R-EE, Nyman J, Dionne D, Hofree M, Cuoco MS, Rodman C, Farouq D et al..  2017.  The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.. Nature. 549(7672):351-356.
Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar A-L, Kabata H, Monticelli LA, Moriyama S, Putzel GGarbès, Rakhilin N et al..  2017.  The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.. Nature. 549(7671):282-286.
Nagashima H, Mahlakõiv T, Shih H-Y, Davis FP, Meylan F, Huang Y, Harrison OJ, Yao C, Mikami Y, Urban JF et al..  2019.  Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.. Immunity.
Veiga-Fernandes H, Artis D.  2018.  Neuronal-immune system cross-talk in homeostasis.. Science. 359(6383):1465-1466.